A new high-throughput liquid chromatography / mass spectrometry (LC-MS) method for the quantification of propofol in human whole blood was developed and validated. The separation was performed on a Gemini NX column under isocratic conditions using a mixture of 0.05 % ammonium hydroxide in water and methanol (23:77, v/v) with a flow rate of 0.6 mL/min. The detection was performed in SIM mode using an ion trap MS equipped with an APCI ion source using negative mode ionization. The whole blood samples (0.2 mL) were deproteinated with methanol before the analysis. The method showed a good linearity (r > 0.997), precision and accuracy (< 10.2%) over the concentration ranges of 0.05 -1.2 μg/mL. The method is not expensive, requires a minimum time for sample preparation and has a run-time of 1.5 min for instrument analysis (retention times for propofol was 0.78 min). The developed and validated LC-MS method is very simple and more rapid than other similar methods. It was successfully applied for the rapid quantification of propofol in human whole blood in forensic toxicology analyses.
) is an anesthetic drug used for both induction and maintenance of anesthesia, as well as for sedation of mechanically ventilated patients in the intensive care unit and for sedation during procedures in or outside the operating room. Subanesthetic doses of propofol show antiemetic properties and can be used to treat postoperative nausea and vomiting [1] . Since 1992, several newspapers (especially forensic) reported cases of abuse, accidental overdose or suicide or criminal purpose with propofol [2] .
Propofol is bound to erythrocytes (50%) and serum proteins (48%) in the blood. It is rapidly metabolized in the liver to hydrosoluble and inactive compounds, which are then excreted through the kidneys. It also shows an extrahepatic metabolism, in which the lungs play a major role contributing to the elimination of up to 30% of a dose of propofol [1] . The propofol blood and brain levels decline rapidly through metabolism and a redistribution from highly perfused (brain) to poorly perfused (skeletal muscles) compartments. The effects have rapid onset (<1 min) and short duration of action (5-10 min) after IV injection [2] .
The analysis of propofol is important both in clinical medicine and in forensic toxicology. Various methods have been reported for the quantification of propofol in plasma or blood: gas chromatography / mass spectrometry (GC-MS) with derivatization [3, 4] and high performance liquid chromatography (HPLC) with UV [5] or fluorescence detection [4, [6] [7] [8] . Recently, several liquid-chromatography / mass spectrometry (LC-MS) or liquid-chromatography / tandem mass spectrometry (LC-MS/MS) methods have been reported for the analysis of propofol in plasma or whole blood [9] [10] [11] [12] .
An isolation step of analytes is often required prior to instrumental analysis, performed generally by liquid-liquid extraction (LLE) [4] [5] [6] or solid phase extraction (SPE) [9, 11] , or by protein precipitation (PP) followed by derivatization [10, 12] . But both extraction and derivatization are time-consuming steps that also increase the cost of the assay and can affect the recovery.
The LC-MS or LC-MS/MS assay offers considerable advantages by its powerful performances: speed, selectivity, sensitivity and robustness. It is preferred especially in forensic purposes [13] [14] [15] [16] . Sample preparation is more simple and rapid and often includes precipitation of proteins (PP) and/or extraction before chromatographic analysis. The aim of this work was to develop and validate a new simple and efficient high throughput LC-MS assay for the rapid quantification of propofol in human whole blood, with large applications in clinical monitoring of the patients or in forensic analysis. Experimental Reagents Standard of propofol was purchased from Lipomed (Switzerland). Methanol of HPLC-grade, ammonium formate, acetic acid and ammonium hydroxide of analytical-reagent grade were purchased from Merck KGaA (Darmstadt, Germany). Bidistilled, deionised water pro injections was obtained from the Laboratory for Infusion Solutions of the University of Medicine and Pharmacy Cluj-Napoca (Romania). The human whole blood was obtained from healthy volunteers, men and women, who didn't use any drug during last seven days.
Apparatus
The following apparatus were used: 204 Sigma Centrifuge (Osterode am Harz, Germany); Analytical Plus and Precision Standard Balance (Mettler-Toledo, Switzerland); Vortex Genie 2 mixer (Scientific Industries, New York, USA); Ultrasonic bath Elma Transsonic 700/H (Singen, Germany). The HPLC system used was an 1100 series Agilent Technologies model (Darmstadt, Germany) consisting of a G1312A binary pump, an in-line G1379A degasser, a G1329A autosampler, a G1316A column thermostat and an Agilent Ion Trap Detector 1100 SL.
Chromatographic and spectrometric conditions Chromatographic separation was performed on a Gemini NX (50 mm x 2.0 mm i.d., 3.5 µm) column (Agilent Technologies) under isocratic conditions using a mobile phase of a mixture of 0.05 % ammonium hydroxide in water and methanol (23:77, v/v) at 30ºC with a flow rate of 0.6 mL/min. The detection was performed in selected ion monitoring (SIM) mode using an ion trap mass spectrometer equipped with an atmospheric pressure chemical ionisation (APCI) ion source, in negative mode (heater 400°C, nebuliser 60 psi, dry gas nitrogen at 7 L/min, dry gas temperature 325ºC, corona 20 µA, capillary 4000V). The monitored ion was m/z 177 for deprotonated molecule of propofol.
Standard solutions
The stock solution of propofol (1 mg/mL) was prepared by dissolving an appropriate quantity in methanol. A working solution (5.0 μg/mL) was prepared by appropriate dilutions in drug-free human whole blood. This solution was used to prepare calibration standards with the concentrations of 0.05, 0.1, 0.2, 0.4, 0.6 and 1.2 μg/mL in drug-free human whole blood. The resultant calibration standards were pipetted into 15 mL polypropylene tubes and stored at -20ºC until analysis. As quality control (QC) samples three concentrations from calibration range were used: second level (lower), fortieth level (medium) and sixtieth level ng/mL (higher).
Sample preparation Whole blood samples (0.2 mL) were treated with methanol (0.5 mL), mixed for 1 min and centrifuged (3 min at 12000 rpm); the supernatants were transferred in autosampler vials and 3.5 μL were injected into the HPLC system. 
Method validation
The concentrations of propofol were determined automatically by the instrument data system using peak areas and the external standard method. The calibration curve model was determined for three calibration series (n = 3) by the least squares analysis: y = c + bx + a*x2, weighted (1/y2) quadratic regression, where y -peak area and x -analyte concentration (μg/mL). The intra-day precision (expressed as coefficient of variation, CV %) and accuracy (expressed as relative difference between obtained and theoretical concentration, bias %) were determined by analysis of three different samples (n = 3) from each QC standards (at lower, medium and higher levels) on the same day. The inter-day precision and accuracy were determined by analysis on three different days (n = 3) of one sample from each QC standards (at lower, medium and higher levels). The lower limit of quantification (LLOQ) was established as the lowest calibration standard with an accuracy and precision less than 20%. The absolute recoveries were measured by comparing the response of the spiked whole blood with the response of standards in solvent with the same concentration of propofol as the whole blood.
Results
The chromatographic conditions, especially the type of ionization source and the composition of the mobile phase, were optimized in several trials to achieve the best MS signals, the shorter retention times for propofol and consequently a high-throughput analysis. Because the molecule of propofol is difficult to protonate, the best results were obtained in negative ionization, using an APCI ion source. The chromatographic separation of analyte was in reverse phase, at 30ºC with a flow rate of 0.6 mL/min and a mixture of an aqueous phase consisting of 0.05% ammonium hydroxide in water and an organic phase consisting of methanol (23:77, V/V). In the selected chromatographic conditions, the retention time of propofol was 0.78 min and the analytical run-time was 1.4 min for instrument analysis. No interfering peaks from the endogenous whole blood components were observed at the retention time of analyte. Representative chromatogram of a sample spiked with propofol at LLOQ is shown in Figure 2 .
The detection was performed in SIM mode by monitoring the deprotonated molecule ion: m/z 177 ( Figure 3 ).
The calibration curves were linear over all the studied concentration range, with the correlation coefficients greater than 0.997. The LLOQ was 0.05 μg/mL. The values obtained for intra-day and interday precision, accuracy and recovery during the validation are shown in Table  1 and Table 2 , respectively. Representative chromatograms of a human whole blood blank (top), of a standard sample spiked with propofol at lower limit of quantification (0.05 μg/mL) (middle) and of a sample from a patient (bottom) 
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Discussion
The other LC-MS/MS methods reported in the literature include an isolation step by solid-phase extraction (SPE) [9, 11] to eliminate the impurities and to increase the sensitivity, or a protein precipitation (PP) followed by a derivatization step [10, 12] . An increase in sensitivity of ca. 200 or 300 times was obtained by derivatization of propofol prior the instrumental assay with dansyl chloride [10] or 2-fluoro-1-methylpyridinum-p-toluene-sulfonate and triethylamine [12] , respectively. However, both operations (extraction and derivatization) increase the time of analysis, increase the costs and can affect the recovery.
Moreover, due to the volatile nature of propofol, the extraction or derivatization step should be done carefully, avoiding possible sample loss during heating procedures [9] . In our method, sample pretreatment (consisting only in PP with methanol and centrifugation) is very simple and rapid and avoid the sample heating. Whole blood is analyzed because much of propofol (98-99%) is bound to erythrocytes and serum proteins, so the possible variations caused by centrifugation of hemolytic blood samples to separate plasma are avoided. This is the first LC-MS method reported in the literature which used the whole blood with only PP and a very short time necessary for sample preparation. Thieme et al used also PP of blood samples with acetonitrile, but with derivatization prior to the instrumental assay [12] .
LC-MS assay
The ionization yield of propofol was tested with both ESI (electrospray ionization) as well as APCI source. The negative ionization mode was chosen because propofol does not have basic moieties in its molecule and is difficult to protonate in order to obtain positive charged ions. The highest ionization yields were obtained with APCI source. Moreover, this ionization source provides less pronounced matrix effects than ESI source [17] , especially because the matrix involved in this work is whole blood. Bajpai et al also preferred to use an APCI source and the negative ionization mode for the same considerations [9] . Ionization efficiency and chromatographic behavior were tested using three components of the aqueous mobile phase: 0.1% acetic acid in water, 2 mM ammonium formate in water, and 0,05% ammonium hydroxide in water. The retention times were not significantly different but the most powerful analytical signal was obtained with 0.05% ammonium hydroxide solution, which was chosen as the mobile phase aqueous component. Other analysts have also preferred the use an ammonium hydroxide solution in mobile phase to obtain best analytical signal [9, 11] .
The selected chromatographic conditions assure a high-throughput analysis, with an analytical runtime of 1.4 min, and the selected detection conditions assure a good sensitivity: LLOQ of 0.05 μg/mL. Other LC-MS/MS published methods for the quantification of propofol in whole blood or plasma samples have longer run-times, even if the sensitivity is better (Table 3) . However, the required plasma concentrations of propofol for maintenance of anesthesia normally range between 3-8 μg/mL and for sedation between 1-2 μg/ mL [1] . Therefore, the sensitivity of our method is good enough to allow clinical monitoring of patients being treated with propofol or propofol detection in forensic toxicological screening. 
Assay validation
The method was validated in accordance with international regulations [18] [19] [20] [21] [22] . The obtained results proved a good linearity (r > 0.997), sensitivity, accuracy and precision over the studied concentration range. All values for accuracy and precision were within recommended limits (Table 1 and Table 2 ). Application The developed method was successfully applied in forensic analysis of a whole blood sample from a patient in a case of suicide (32 years women (M.A.), sample taken in Forensic Institute Cluj-Napoca). The representative chromatogram is showed in Figure 2 . The concentration of propofol found was 0.494 μg/mL.
